Key facts
- (Navari)’s last known valuation is $2.7M (Nov 2022).
- It has raised $1.3M; the latest was Seed Round ($570K) in May 2025.
- Notable investors include Almi Invest, Chalmers Ventures, First Gate Invest, GU Ventures, Nordic Innovation House - Silicon Valley — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for (Navari)
- ·The full record, as it builds
Funding rounds
No funding rounds for (Navari) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About (Navari)
Developer of an augmented reality tool designed to improve laparoscopic liver surgery. The company's tools use algorithms to present the surgeons with a live-streamed augmented reality image of the tumor and its exact position in the liver on top of the two-dimensional laparoscopic camera picture, enabling surgeons to simplify the navigation during surgery and increase the precision of tumor removal.
- Sector
- Healthcare
- HQ
- Gothenburg, Sweden
- Founded
- 2021
- Employees
- 10
- Website
- navarisurgical.com/
- Ownership
- Privately Held (backing)
(Navari) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in (Navari) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on (Navari) in its N-PORT filings yet. We sweep new filings monthly.